Cargando…
Targeting chemoresistance in Xp11.2 translocation renal cell carcinoma using a novel polyamide–chlorambucil conjugate
Renal cell carcinoma with Xp11.2 translocation involving the TFE3 gene (TFE3‐RCC) is a recently identified subset of RCC with unique morphology and clinical presentation. The chimeric PRCC‐TFE3 protein produced by Xp11.2 translocation has been shown to transcriptionally activate its downstream targe...
Autores principales: | Funasaki, Shintaro, Mehanna, Sally, Ma, Wenjuan, Nishizawa, Hidekazu, Kamikubo, Yasuhiko, Sugiyama, Hiroshi, Ikeda, Shuji, Motoshima, Takanobu, Hasumi, Hisashi, Linehan, W. Marston, Schmidt, Laura S., Ricketts, Chris, Suda, Toshio, Oike, Yuichi, Kamba, Tomomi, Baba, Masaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277412/ https://www.ncbi.nlm.nih.gov/pubmed/35396773 http://dx.doi.org/10.1111/cas.15364 |
Ejemplares similares
-
MicroRNA‐204‐5p: A novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma
por: Kurahashi, Ryoma, et al.
Publicado: (2019) -
Growth Arrest of BCR-ABL Positive Cells with a Sequence-Specific Polyamide-Chlorambucil Conjugate
por: Chou, C. James, et al.
Publicado: (2008) -
Clinicopathological features of Xp11.2 translocation renal cell carcinoma
por: Lim, Bumjin, et al.
Publicado: (2015) -
Xp11.2 translocation renal cell carcinomas in young adults
por: Xu, Linfeng, et al.
Publicado: (2015) -
Xp11.2 Translocation Renal Cell Carcinoma Diagnosed by Immunohistochemistry and Cytogenetics
por: Dey, Biswajit, et al.
Publicado: (2016)